Genetic posterior fossa malformation

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:269557
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Genetic posterior fossa malformation (Orphanet code 269557) is a broad grouping term that encompasses a heterogeneous collection of rare congenital brain malformations affecting structures within the posterior fossa, which contains the cerebellum, brainstem, and fourth ventricle. These malformations arise from disruptions in the normal embryological development of posterior fossa structures and have an identifiable genetic basis, distinguishing them from acquired or purely sporadic forms. Specific conditions within this category include Dandy-Walker malformation, Joubert syndrome, rhombencephalosynapsis, cerebellar hypoplasia, and various pontocerebellar hypoplasias, among others. Clinical features vary widely depending on the specific malformation but commonly include motor developmental delay, hypotonia, ataxia (impaired coordination), intellectual disability, abnormal eye movements (such as oculomotor apraxia), and breathing irregularities in neonates. Hydrocephalus may develop due to obstruction of cerebrospinal fluid flow. Some forms are associated with additional systemic involvement including renal cysts, hepatic fibrosis, retinal dystrophy, or skeletal anomalies, particularly in ciliopathy-related conditions such as Joubert syndrome and related disorders. Because this is a classification group rather than a single disease entity, the genetic basis is highly variable, involving numerous genes with autosomal recessive, autosomal dominant, or X-linked inheritance patterns depending on the specific condition. Diagnosis typically relies on brain MRI demonstrating characteristic posterior fossa abnormalities, combined with genetic testing (exome or genome sequencing, gene panels). Treatment is supportive and symptom-directed, including neurosurgical intervention for hydrocephalus, physical and occupational therapy for motor impairments, speech therapy, and management of associated organ involvement. No curative therapies currently exist for the underlying genetic causes.

Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Genetic posterior fossa malformation.

View clinical trials →

No actively recruiting trials found for Genetic posterior fossa malformation at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Genetic posterior fossa malformation community →

No specialists are currently listed for Genetic posterior fossa malformation.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Genetic posterior fossa malformation.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Genetic posterior fossa malformationForum →

No community posts yet. Be the first to share your experience with Genetic posterior fossa malformation.

Start the conversation →

Latest news about Genetic posterior fossa malformation

No recent news articles for Genetic posterior fossa malformation.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Genetic posterior fossa malformation

What is Genetic posterior fossa malformation?

Genetic posterior fossa malformation (Orphanet code 269557) is a broad grouping term that encompasses a heterogeneous collection of rare congenital brain malformations affecting structures within the posterior fossa, which contains the cerebellum, brainstem, and fourth ventricle. These malformations arise from disruptions in the normal embryological development of posterior fossa structures and have an identifiable genetic basis, distinguishing them from acquired or purely sporadic forms. Specific conditions within this category include Dandy-Walker malformation, Joubert syndrome, rhombencepha

At what age does Genetic posterior fossa malformation typically begin?

Typical onset of Genetic posterior fossa malformation is neonatal. Age of onset can vary across affected individuals.